WORCESTER, Mass., May 28, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) announced today that Dr. Douglas Powell, Director of Immunobiology at Antigen Express, Inc. (www.antigenexpress.com), Generex’s wholly-owned immunotherapeutics subsidiary, will participate in a panel discussion this afternoon at the Human Swine Flu (H1N1) and Novel Influenza Pandemics symposium being hosted by The New York Academy of Sciences (NYAS) to be held at the NYAS conference center in New York City. The symposium will feature presentations by leaders in the field and will explore the latest swine influenza (H1N1 flu) outbreak with talks on the new reassortant virus, epidemiology, vaccines, treatment, and public health aspects.
